Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


04.06.2018

2 Ann Hematol
4 Blood
1 BMC Cancer
2 Bone Marrow Transplant
2 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
1 Cell
1 Exp Hematol
1 Int J Hematol
3 J Clin Oncol
1 J Pediatr Hematol Oncol
3 N Engl J Med
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Hematol

  1. IWASHIGE A, Hirosawa M, Tsukada J
    Hairy cell leukemia presenting with progressive pericarditis and pleuritis.
    Ann Hematol. 2018 May 30. pii: 10.1007/s00277-018-3378.
    PubMed     Text format    

  2. MOLICA M, Scalzulli E, Colafigli G, Fegatelli DA, et al
    Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.
    Ann Hematol. 2018 May 27. pii: 10.1007/s00277-018-3375.
    PubMed     Text format     Abstract available


    Blood

  3. PATEL SS, Dorfman DM
    Leukemic-phase progression of aleukemic mast cell leukemia.
    Blood. 2018;131:2406.
    PubMed     Text format    

  4. ALDOSS I, Song JY
    Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.
    Blood. 2018;131:2507.
    PubMed     Text format    

  5. LEBLANC TW, Egan PC, Olszewski AJ
    Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia.
    Blood. 2018 May 30. pii: blood-2018-03-842575. doi: 10.1182/blood-2018-03-842575
    PubMed     Text format     Abstract available

  6. MELO-CARDENAS J, Xu Y, Wei J, Tan C, et al
    USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1 dependent mechanism.
    Blood. 2018 May 29. pii: blood-2017-10-811760. doi: 10.1182/blood-2017-10-811760
    PubMed     Text format     Abstract available


    BMC Cancer

  7. LI F, Zhang X, Wang Y, Yang A, et al
    Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations.
    BMC Cancer. 2018;18:604.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  8. CRADDOCK C, Hoelzer D, Komanduri KV
    Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia.
    Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0203.
    PubMed     Text format     Abstract available

  9. KATO M, Kurata M, Kanda J, Kato K, et al
    Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
    PubMed     Text format     Abstract available


    Cancer

  10. ARELLANO M, Carlisle JW
    How I treat older patients with acute myeloid leukemia.
    Cancer. 2018 May 29. doi: 10.1002/cncr.31347.
    PubMed     Text format    

  11. GORDON MJ, Churnetski M, Alqahtani H, Rivera X, et al
    Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31554.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  12. GAO C, Hu S, Guo M, Hai X, et al
    Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Cancer Chemother Pharmacol. 2018 May 29. pii: 10.1007/s00280-018-3606.
    PubMed     Text format     Abstract available


    Cancer Lett

  13. ZHANG X, Zheng X, Yang H, Yan J, et al
    Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis.
    Cancer Lett. 2018 May 29. pii: S0304-3835(18)30367.
    PubMed     Text format     Abstract available


    Cell

  14. KIM MY, Yu KR, Kenderian SS, Ruella M, et al
    Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
    Cell. 2018;173:1439-1453.
    PubMed     Text format     Abstract available


    Exp Hematol

  15. NICOLINI FE, Alcazer V, Cony-Makhoul P, Heiblig M, et al
    Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line.
    Exp Hematol. 2018 May 22. pii: S0301-472X(18)30259.
    PubMed     Text format     Abstract available


    Int J Hematol

  16. SATO K, Sakai H, Saiki Y, Uchida A, et al
    Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia.
    Int J Hematol. 2018 May 29. pii: 10.1007/s12185-018-2472.
    PubMed     Text format     Abstract available


    J Clin Oncol

  17. ROSS DM, Burbury KL, Grigg AP, Hughes TP, et al
    Management of Pregnancy in Women With Chronic Myeloid Leukemia.
    J Clin Oncol. 2018 May 31:JCO2018786137. doi: 10.1200/JCO.2018.78.6137.
    PubMed     Text format    

  18. VAREDI M, Lu L, Howell CR, Partin RE, et al
    Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 May 29:JCO2017767871. doi: 10.1200/JCO.2017.76.7871.
    PubMed     Text format     Abstract available

  19. SLAYTON WB, Schultz KR, Kairalla JA, Devidas M, et al
    Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
    J Clin Oncol. 2018 May 29:JCO2017767228. doi: 10.1200/JCO.2017.76.7228.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  20. VEDI A, Mitchell R, Shanmuganathan S, Oswald C, et al
    Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
    J Pediatr Hematol Oncol. 2018 May 22. doi: 10.1097/MPH.0000000000001215.
    PubMed     Text format     Abstract available


    N Engl J Med

  21. COPUR MS, Gauchan D, Crockett D
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2142-3.
    PubMed     Text format    

  22. FERHANOGLU B, Ozturk E, Ozbalak M
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2.
    PubMed     Text format    


  23. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2144.
    PubMed     Text format    


    Oncol Rep

  24. ZOVKO A, Yektaei-Karin E, Salamon D, Nilsson A, et al
    Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Oncol Rep. 2018 May 25. doi: 10.3892/or.2018.6465.
    PubMed     Text format     Abstract available


    PLoS One

  25. KSIONDA O, Mues M, Wandler AM, Donker L, et al
    Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
    PLoS One. 2018;13:e0193849.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: